Product
11C-HY-2-15
1 clinical trial
1 indication
Indication
TauopathyClinical trial
Center Without Walls for Imaging Proteinopathies With PET (CW2IP2): Phase I Pilot Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15Status: Recruiting, Estimated PCD: 2028-07-31